Sotera Health Announces Second-Quarter 2026 Earnings Release Date

Rhea-AI Summary

Sotera Health (Nasdaq: SHC) plans to release its financial results for the second quarter ended June 30, 2026, before the market opens on Thursday, August 6, 2026. Management will host a conference call at 9:00 a.m. EDT, with a live webcast and replay available via the company’s Investor Relations website.

News Market Reaction – SHC

+1.16%

+1.16% Session close to close

In the Jul 23 session, SHC gained 1.16%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

Historical earnings-date announcements recorded -1.9% and -0.18% 24-hour reactions. That record cont...

Analysis

Historical earnings-date announcements recorded -1.9% and -0.18% 24-hour reactions. That record contextualizes this scheduling notice; the August 6 release will provide the operating data, while reported Net Selling is a separate risk factor to monitor.

Key Figures

Reporting period end: June 30, 2026 Results release date: August 6, 2026 Conference call time: 9:00 a.m. Eastern Daylight Time

3 metrics

Reporting period end June 30, 2026 Second-quarter 2026

Results release date August 6, 2026 Before the market opens

Conference call time 9:00 a.m. Eastern Daylight Time August 6, 2026

Previous Earnings date Reports

2 past events · Latest: Apr 21 (Neutral)

Same Type Pattern 2 events

Date	Event	Sentiment	24h Move	Catalyst
Apr 21	1Q26 earnings date	Neutral	-1.9%	Release-date notice preceded a 1.9% 24-hour decline.
Feb 17	4Q25 earnings date	Neutral	-0.2%	Release-date notice preceded a 0.18% 24-hour decline.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

The two prior earnings-date announcements were followed by negative 24-hour reactions of -1.9% and -0.18%, with an average move of -1.04%.

Key Terms

ethylene oxide

1 terms

ethylene oxide technical

"For developments related to Ethylene Oxide, updates can be found"

Ethylene oxide is a flammable, colorless gas used industrially to make plastics and other chemicals and as a sterilizing agent for medical equipment. Investors should care because its use and emissions are tightly regulated—like a tool that can both build products and create legal or cleanup costs—so changes in safety findings, permits, or supply disruptions can affect manufacturing, liabilities, and company valuations.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

CLEVELAND, July 23, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced its plans to release its financial results for the second-quarter ended June 30, 2026 before the market opens on Thursday, August 6, 2026. Following the release, management will host a conference call at 9:00 a.m. Eastern Daylight Time to discuss the Company’s operating and financial results.

A live webcast of the conference call and accompanying materials can be accessed via the Investor Relations section of the Company’s website at Presentation & Events | Sotera Health. A replay of the webcast will be available later in the day on August 6.

Updates on recent developments in matters relevant to investors can be found on the Investor Relations section of the Sotera Health website at Investor Relations | Sotera Health. For developments related to Ethylene Oxide, updates can be found at Ethylene Oxide | Sotera Health.

About Sotera Health
Sotera Health Company is a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry. Sotera Health goes to market through three businesses – Sterigenics^®, Nordion^® and Nelson Labs^®. Sotera Health is committed to its mission, Safeguarding Global Health^®.

Contacts
Jason Peterson Vice President, Investor Relations IR@soterahealth.com
Kristin Gibbs Chief Marketing Officer, Sotera Health kgibbs@soterahealth.com

FAQ

When will Sotera Health (SHC) release its Q2 2026 earnings results?

Sotera Health plans to release its Q2 2026 financial results before the market opens on Thursday, August 6, 2026. According to the company, these results will cover the quarter ended June 30, 2026.

What time is Sotera Health's Q2 2026 earnings conference call on August 6, 2026?

The Q2 2026 earnings conference call is scheduled for 9:00 a.m. Eastern Daylight Time on August 6, 2026. According to Sotera Health, management will discuss operating and financial results during this call.

How can investors access Sotera Health's (SHC) Q2 2026 earnings webcast?

Investors can access the live Q2 2026 earnings webcast via the Investor Relations section of the Sotera Health website. According to the company, accompanying materials and a replay will also be available there.

Will a replay of Sotera Health's Q2 2026 earnings call be available to investors?

Yes, a replay of the Q2 2026 earnings webcast will be available later on August 6, 2026. According to Sotera Health, the replay can be accessed through the Investor Relations section of its website.

Where can investors find updates on Sotera Health (SHC) and ethylene oxide developments?

Investors can find general updates in the Investor Relations section of the Sotera Health website. According to the company, developments related specifically to ethylene oxide are available on its dedicated “Ethylene Oxide” webpage.

What business does Sotera Health operate through Sterigenics, Nordion and Nelson Labs?

Sotera Health is described as a leading global provider of sterilization, lab testing and advisory services. According to the company, it goes to market through three businesses: Sterigenics, Nordion and Nelson Labs.

Who are the investor relations and marketing contacts for Sotera Health (SHC)?

According to Sotera Health, investor relations inquiries can be directed to Jason Peterson, Vice President, Investor Relations. Marketing-related inquiries can be directed to Kristin Gibbs, Chief Marketing Officer, using the emails provided by the company.